Skip to main content

Advertisement

SpringerLink
Log in

Association of Plasma Adiponectin Concentrations with Chronic Lymphocytic Leukemia and Myeloproliferative Diseases

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Adiponectin, an adipocyte-secreted hormone, is an important negative regulator in the immune system and hematopoiesis. In this study, we investigated the association of adiponectin levels with chronic lymphocytic leukemia (CLL) and myeloproliferative diseases (MPDs). We measured adiponectin levels in 19 patients with CLL and 30 patients with MPD (chronic myelogenous leukemia, 15; polycythemia vera, 9; myelofibrosis, 4; essential thrombocythemia, 2). The data were compared with results from a control group of healthy volunteers who were matched according to age, sex, and body mass index. The adiponectin levels in patients with CLL were lower than in the controls (4.71 ± 1.33 μg/mL versus 16.61 ± 3.91 μg/mL; P < .001). They were also significantly lower in patients with MPD than in the controls (8.95 ± 2.64 μg/mL versus 17.16 ± 4.77 μg/mL; P < .001). In addition, we compared the adiponectin levels of MPD patients who were treated with interferon (IFN) to the levels of patients who were not treated with IFN. Adiponectin levels were significantly higher in IFN-treated patients (11.03 ± 1.39 μg/mL versus 6.87 ± 1.79 μg/mL; P < .001). These results suggest that lymphopoiesis and myelopoiesis negatively influence adiponectin levels. Adiponectin may be related to inflammatory cytokine release. IFN therapy appears to have a positive influence on adiponectin secretion by suppressing inflammatory cytokines. Future studies are needed to prove causality and to provide insight about this hormone’s mechanism of action and its potential role regarding the etiology and progression of CLL and MPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221:286–289.

    Article  PubMed  CAS  Google Scholar 

  2. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo). 1996;120:803–812.

    Article  CAS  Google Scholar 

  3. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96:1723–1732.

    PubMed  CAS  Google Scholar 

  4. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1220-R1225.

    Article  PubMed  CAS  Google Scholar 

  5. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962–971.

    Article  PubMed  CAS  Google Scholar 

  6. Bourantas KL, Hatzimichael EC, Makis AC, et al. Serum beta-2-microglobulin, TNF-α and interleukins in myeloproliferative disorders. Eur J Haematol. 1999;63:19–25.

    Article  PubMed  CAS  Google Scholar 

  7. Hulkkonen J, Vilpo J, Vilpo L, Koski T, Hurme M. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica. 2000;85:600–606.

    PubMed  CAS  Google Scholar 

  8. Hulkkonen J, Vilpo J, Vilpo L, Hurme M, for the Tampere CLL Group. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Br J Haematol. 1998;100:478–483.

    Article  PubMed  CAS  Google Scholar 

  9. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.

    Google Scholar 

  10. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol. 1997;34:29–39.

    PubMed  CAS  Google Scholar 

  11. Barosi G, Ambrosetti A, Finelli C, et al. The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J Haematol. 1999;104:730–737.

    Article  PubMed  CAS  Google Scholar 

  12. Tefferi A. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Mayo Clin Proc. 1998;73:1177–1184.

    Article  PubMed  CAS  Google Scholar 

  13. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173–180.

    Article  PubMed  CAS  Google Scholar 

  14. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002;103:137–142.

    Article  CAS  Google Scholar 

  15. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293–300.

    Article  PubMed  CAS  Google Scholar 

  16. Yilmaz MI, Sonmez A, Kilic S, et al. The association of plasma adiponectin level with hypertensive retinopathy. Eur J Endocrinol. 2005;152:233–240.

    Article  PubMed  CAS  Google Scholar 

  17. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746–26749.

    Article  PubMed  CAS  Google Scholar 

  18. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084–1089.

    Article  PubMed  CAS  Google Scholar 

  19. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res. 2000;32:548–554.

    Article  PubMed  CAS  Google Scholar 

  20. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr. 2005;15:131–136.

    Article  PubMed  Google Scholar 

  21. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNF-α, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab. 2003;285:E1072-E1080.

    Article  PubMed  CAS  Google Scholar 

  22. Mainou-Fowler T, Miller S, Proctor SJ, Dickinson AM. The levels of TNFa, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Res. 2001;25:157–163.

    Article  PubMed  CAS  Google Scholar 

  23. Mavridis AK, Tsiara S, Makis A, et al. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia. J Exp Clin Cancer Res. 1998;17:445–448.

    PubMed  CAS  Google Scholar 

  24. Hotamisligil GS. The role of TNFa and TNF receptors in obesity and insulin resistance. J Intern Med. 1999;245:621–625.

    Article  PubMed  CAS  Google Scholar 

  25. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391–3399.

    Article  PubMed  CAS  Google Scholar 

  26. Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep. 2003;3:207–213.

    Article  PubMed  Google Scholar 

  27. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002;13:51–59.

    Article  PubMed  CAS  Google Scholar 

  28. Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004;101:2476–2481.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Le Bousse-Kerdiles MC, Souyri M, Smadja-Joffe F, Praloran V, Jasmin C, Ziltener HJ. Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome. Blood. 1992;79:3179–3187.

    PubMed  Google Scholar 

  30. Elias JA, Lentz V IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol. 1990;145:161–166.

    PubMed  CAS  Google Scholar 

  31. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol. 1992;62(1 Pt 2):S60-S65.

    Article  PubMed  CAS  Google Scholar 

  32. Le JM, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 1989;61:588–602.

    PubMed  CAS  Google Scholar 

  33. Blay JY, Favrot M, Rossi JF, Wijdenes J. Role of interleukin-6 in paraneoplastic thrombocytosis. Blood. 1993;82:2261–2262.

    PubMed  CAS  Google Scholar 

  34. Taylor JL, Grossberg SE. The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol. 1998;25(1 suppl 1):23–29.

    PubMed  CAS  Google Scholar 

  35. Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB. A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol. 1987;7:273–280.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Tilg H, Mier JW, Vogel W, et al. Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol. 1993;150:4687–4692.

    PubMed  CAS  Google Scholar 

  37. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J. Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci U S A. 1992;89:9049–9053.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med. 1988;167:1883–1893.

    Article  PubMed  CAS  Google Scholar 

  39. Aman MJ, Rudolf G, Goldschmitt J, et al. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood. 1993;82:2371–2378.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Gulhane Military Medical Academy, School of Medicine, 06010, Ankara, Etlik, Turkey

    Ferit Avcu, A. Ugur Ural & Oral Nevruz

  2. Medical and Cancer Research Center, Ankara, Turkey

    Ferit Avcu & A. Ugur Ural

  3. Nephrology, Gulhane Military Medical Academy, Ankara, Turkey

    M. Ilker Yilmaz & Kayser Caglarc

  4. Department of Biochemistry, Bayindir Medical Center, Ankara, Turkey

    Necati Bingol

Authors
  1. Ferit Avcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Ugur Ural
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Ilker Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Necati Bingol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Oral Nevruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kayser Caglarc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferit Avcu.

About this article

Cite this article

Avcu, F., Ural, A.U., Yilmaz, M.I. et al. Association of Plasma Adiponectin Concentrations with Chronic Lymphocytic Leukemia and Myeloproliferative Diseases. Int J Hematol 83, 254–258 (2006). https://doi.org/10.1532/IJH97.NA0411

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.NA0411

Key words

Search

Navigation